Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SIRAKI02 POST-HOC ANALYSIS.

NCT06781294 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT06781294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06781294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SIRAKI02 POST-HOC ANALYSIS.
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2024
Completion date
March 1, 2027
Enrollment
343 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiac surgery requiring cardiopulmonary bypass, chronic kidney disease(ckd), kidney failure, acute